세계의 중심 정맥 카테터 시장 : 제품별, 특성별, 디자인별, 조성별, 최종 사용자별, 지역별 세계 분석 예측(-2030년)

According to Stratistics MRC, the Global Central Venous Catheter Market is accounted for $2861.0 million in 2024 and is expected to reach $4693.5 million by 2030 growing at a CAGR of 8.6% during the forecast period. A Central Venous Catheter (CVC) is a medical device inserted into a large vein, often in the neck, chest, or groin, to deliver medications, fluids, or nutrients, or to collect blood samples. It is commonly used in critically ill patients or those undergoing prolonged treatments such as chemotherapy or dialysis. CVCs are designed for long-term access to the central venous system, offering a safer alternative to peripheral intravenous lines. Their use carries risks such as infection or thrombosis, requiring careful management.

According to the World Health Organization (WHO) approximately 30 million people are diagnosed every year with sepsis.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and kidney diseases, often require long-term treatment such as chemotherapy, dialysis, or intravenous medicine, where CVCs are crucial. As the global population increases, the incidence of these chronic conditions increases further boosts demand. Additionally, advancements in CVC technology, offering better safety and efficiency, have contributed to their growing adoption. Healthcare systems are focusing more on critical care, further accelerating the use of CVCs. The combination of higher patient volumes and the need for specialized medical care propels market growth.

Restraint:

Risk of infection and complications

The risk of infection and complications, such as catheter-related bloodstream infections (CRBSIs) and thrombosis, can lead to longer hospital stays, increased healthcare costs, and patient morbidity. As a result, healthcare providers are cautious about CVC usage, which may limit their adoption. Moreover, stringent infection control regulations and the need for specialized training further complicate CVC implementation. Product recalls due to safety concerns also negatively affect market confidence. Despite innovations in infection-resistant designs, these risks remain a significant barrier.

Opportunity:

Product innovation

Product innovation such as those with antimicrobial coatings, help reduce infection risks, addressing one of the major concerns associated with CVC use. Additionally, the development of more durable and user-friendly catheters has improved patient outcomes and healthcare provider satisfaction. Advances in catheter materials, making them more flexible and biocompatible, also contribute to longer-term usage. These innovations not only drive market growth but also help meet the increasing demand for safe, effective medical devices in critical care settings. As a result, healthcare providers are more likely to adopt new technologies, further expanding the market.

Threat:

Cost and healthcare budget constraints

High costs associated with CVC devices and their insertion procedures limit their adoption, especially in low-resource settings. Budget constraints in hospitals can lead to prioritization of essential treatments, reducing the allocation for advanced medical devices like CVCs. Additionally; hospitals may opt for cheaper alternatives, potentially compromising patient care quality. The increasing need for cost-efficient solutions and resource optimization adds pressure on the CVC market. Hospitals, particularly in emerging markets, may struggle with the affordability of high-quality catheters. This can slow down the adoption of newer, more effective CVC technologies.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the central venous catheter (CVC) market, leading to supply chain disruptions, delays in elective procedures, and a shift in healthcare priorities toward COVID-19 treatment. This reduced the demand for non-urgent medical procedures, affecting CVC usage in hospitals. However, the pandemic also increased the need for critical care and long-term treatments in severely ill patients, creating demand for CVCs. As the healthcare system adapts post-pandemic, the market is recovering with renewed focus on safety and infection prevention.

The antimicrobial catheters segment is expected to be the largest during the forecast period

The antimicrobial catheters segment is estimated to have a lucrative growth, due to the increasing risk of infections associated with traditional catheters. These specialized catheters are coated with antimicrobial agents that reduce the likelihood of infections, a major concern for healthcare providers. As hospitals aim to enhance patient safety, the demand for antimicrobial CVCs is rising. Additionally, these catheters improve patient outcomes by lowering healthcare-associated infections, which ultimately reduces treatment costs. Technological advancements in antimicrobial coatings further boost market growth.

The specialized clinics segment is expected to have the highest CAGR during the forecast period

The specialized clinics segment is anticipated to witness the highest CAGR growth during the forecast period, by offering focused care for chronic conditions like cancer, cardiovascular diseases, and kidney disorders. These clinics provide tailored treatments, including chemotherapy and dialysis, where CVCs are essential for long-term medication administration. The increased prevalence of such conditions fuels the demand for specialized, continuous care, boosting the use of CVCs. Furthermore, these clinics often have advanced facilities and medical expertise, ensuring safer CVC usage. With rising patient numbers and improved healthcare infrastructure, specialized clinics are a key segment propelling market expansion. This trend is expected to continue, particularly as more specialized clinics emerge in emerging markets.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period driven by the rising prevalence of chronic diseases like cancer, cardiovascular diseases, and kidney disorders. The increasing number of specialized clinics and healthcare facilities in countries such as China, India, and Japan is enhancing access to critical care treatments, further boosting CVC demand. Additionally, improvements in healthcare infrastructure and rising awareness about advanced medical treatments are propelling market expansion. As a result, Asia-Pacific is expected to be a key contributor to the global CVC market's growth in the coming years.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the region's high prevalence of chronic diseases like cancer, cardiovascular disorders, and kidney conditions. Advanced healthcare infrastructure and the increasing number of specialized clinics and hospitals in North America also boost demand for CVCs. Additionally, technological innovations in catheter design, which reduce infection risks and improve patient outcomes, are propelling the market. The aging population and the growing number of long-term treatments, such as chemotherapy and dialysis, further support market expansion. Regulatory standards and a well-established healthcare system are expected to sustain this growth trajectory.

Key players in the market

Some of the key players profiled in the Central Venous Catheter Market include ICU Medical, Inc., B. Braun SE, Becton, Dickinson and Company, Poly Medicure Ltd., Lepu Medical Technology Co., Ltd., Teleflex Incorporated, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, Kimal, Medtronic, Rex Medical, LLC, Asahi Kasei Corporation and AngioDynamics, Inc.

Key Developments:

In November 2024, ICU Medical announced the creation of a joint venture with Otsuka Pharmaceutical Factory, Inc. This collaboration aims to enhance IV solutions manufacturing and innovation in North America.

In June 2024, B. Braun sold its global orthobiologics business, including TETEC AG in Germany and Aesculap Biologics LLC in the U.S., to Octane Medical Group. This transfer included products such as NOVOCART 3D and NOVOCART Inject, which are innovative cartilage repair solutions.

In May 2024, B. Braun introduced the Flexiva TractSeal Mini Fiber in May 2024. This innovative product is designed for minimally invasive laser lithotripsy, ensuring efficiency in urinary stone treatment. It highlights B. Braun's commitment to expanding its minimally invasive medical technologies portfolio.

Products Covered:

• Tunneled Catheters
• Non-Tunneled Catheters

Properties Covered:

• Antimicrobial Catheters
• Non-Antimicrobial Catheters

Designs Covered:

• Single Lumen
• Double Lumen
• Multiple Lumen

Compositions Covered:

• Polyurethane
• Teflon
• Silicone Rubber
• Other Compositions

End Users Covered:

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Cancer Research Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Central Venous Catheter Market, By Product

• 5.1 Introduction
• 5.2 Tunneled Catheters
• 5.3 Non-Tunneled Catheters

6 Global Central Venous Catheter Market, By Property

• 6.1 Introduction
• 6.2 Antimicrobial Catheters
• 6.3 Non-Antimicrobial Catheters

7 Global Central Venous Catheter Market, By Design

• 7.1 Introduction
• 7.2 Single Lumen
• 7.3 Double Lumen
• 7.4 Multiple Lumen

8 Global Central Venous Catheter Market, By Composition

• 8.1 Introduction
• 8.2 Polyurethane
• 8.3 Teflon
• 8.4 Silicone Rubber
• 8.5 Other Compositions

9 Global Central Venous Catheter Market, By End User

• 9.1 Introduction
• 9.2 Hospitals
• 9.3 Ambulatory Surgical Centers
• 9.4 Specialized Clinics
• 9.5 Cancer Research Institutes
• 9.6 Other End Users

10 Global Central Venous Catheter Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 ICU Medical, Inc.
• 12.2 B. Braun SE
• 12.3 Becton, Dickinson and Company
• 12.4 Poly Medicure Ltd.
• 12.5 Lepu Medical Technology Co., Ltd.
• 12.6 Teleflex Incorporated
• 12.7 VOGT Medical
• 12.8 ZOLL Medical Corporation
• 12.9 EETA Surgical
• 12.10 QMD
• 12.11 Kimal
• 12.12 Medtronic
• 12.12 Rex Medical, LLC
• 12.14 Asahi Kasei Corporation
• 12.15 AngioDynamics, Inc.